kabutan

TORII PHARMACEUTICAL CO., LTD.(4551) Summary

4551
TORII PHARMACEUTICAL CO., LTD.
JPY
+20
(+0.32%)
Aug 27, 3:30 pm JST
USD
Aug 27, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
52.5
PBR
1.46
Yield
ー%
Margin Trading Ratio
34.16
Stock Price
Aug 27, 2025
Opening Aug 27, 9:00 am
6,340 JPY 42.99 USD
Previous Close Aug 26
6,330 JPY 42.83 USD
High Aug 27, 9:05 am
6,350 JPY 43.06 USD
Low Aug 27, 9:06 am
6,330 JPY 42.78 USD
Volume
48,100
Trading Value
0.31B JPY 2.06M USD
VWAP
6334.03 JPY 42.88 USD
Minimum Trading Value
635,000 JPY 4,297 USD
Market Cap
0.18T JPY 1.24B USD
Number of Trades
43
Liquidity & Number of Trades
As of Aug 27, 2025
Liquidity
Mid
1-Year Average
304
1-Year High May 8, 2025
3,601
Margin Trading
Date Short Interest Long Margin Positions Ratio
Aug 22, 2025 800 100 0.13
Aug 15, 2025 1,000 200 0.20
Aug 8, 2025 1,200 1,500 1.25
Aug 1, 2025 1,200 4,900 4.08
Jul 25, 2025 1,300 2,600 2.00
Company Profile
TORII PHARMACEUTICAL CO., LTD. is a subsidiary of JT Group, with strengths in cardiovascular products. The company is strengthening its development in renal and dialysis, dermatological, and allergen areas.
Sector
Pharmaceuticals
TORII PHARMACEUTICAL CO., LTD.'s main business is the manufacture and sale of pharmaceuticals, with JT holding a majority stake in the company and collaborating on operational aspects. The company offers a wide range of products, focusing on renal and dialysis, dermatological, and allergen areas. In the renal and dialysis field, they manufacture and sell treatments for hyperphosphatemia and oral medications for pruritus improvement. In dermatology, they offer topical corticosteroids and antifungal drugs. For allergens, they produce allergen immunotherapy drugs for Japanese cedar pollinosis and dust mite allergies. Additionally, they manufacture and sell antidiarrheal agents and plasma kallikrein inhibitors. TORII PHARMACEUTICAL CO., LTD. has built a product lineup combining in-house developed and in-licensed products to address diverse medical needs.